The immune response combines extraordinary specificity of recognition with extremely complex control mechanisms that govern its effector mechanisms. Childhood primary immunodeficiency disorders can be viewed as """"""""experiments of nature"""""""" in which a discrete genetic defect affects the expression and/or the structure/function of essential lymphocyte proteins and results in immune dysfunctions. A molecular or genetic definition of primary immunodeficiencies is essential for accurate diagnosis and therapy of the disorders and for better understanding of normal immune functions. In this program project, we propose to study a limited set of immunological diseases because of our success in analyzing both patient materials as well as transgenic mice models. We will use recently acquired knowledge of the causes of the X-Linked hyper IgM syndrome, the X-linked agammaglobunemia, severe combined immunodeficiencies, and T cell receptor deficiencies. We anticipate extensive usage of molecular biology and cell biology techniques to further define these diseases. Novel transgenic animal models, which we generated or which we are developing will also become powerful tools for a systematic dissection of the biochemical processes, which govern ontogeny of the immune system. The four scientific components of the Program are: Project 1: Transgenic Models of T Cell Receptor Immunodeficiencies. Cox Terhorst, Beth Israel Hospital. Project 2: HIGMX-1: Transgenic Models of CD40 and CD40L deficiency. Raif Geha and Fred Rosen, Children's Hospital. Project 3: Murine XLA and SCID Models. Frederick ALT and Fred Rosen, The Center for blood Research. Immunodeficiency Patient Core Facility Raif Geha and Fred Rosen, Children's Hospital.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Allergy & Clinical Immunology-1 (AITC)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Beth Israel Deaconess Medical Center
United States
Zip Code
Sayos, J; Wu, C; Morra, M et al. (2017) Pillars Article: The X-Linked Lymphoproliferative Disease Gene Product SAP Regulates Signals Induced through the Co-Receptor SLAM. Nature. 1998. 395: 462-469. J Immunol 199:1534-1541
Chaudhary, Anu; Leite, Mara; Kulasekara, Bridget R et al. (2016) Human Diversity in a Cell Surface Receptor that Inhibits Autophagy. Curr Biol 26:1791-801
Jabri, Bana; Terhorst, Cox (2014) Editorial overview: Autoimmunity. Curr Opin Immunol 31:v-vii
Sintes, Jordi; Cuenca, Marta; Romero, Xavier et al. (2013) Cutting edge: Ly9 (CD229), a SLAM family receptor, negatively regulates the development of thymic innate memory-like CD8+ T and invariant NKT cells. J Immunol 190:21-6
Detre, Cynthia; Keszei, Marton; Garrido-Mesa, Natividad et al. (2012) SAP expression in invariant NKT cells is required for cognate help to support B-cell responses. Blood 120:122-9
McDonald, Douglas R; Massaad, Michel J; Johnston, Alicia et al. (2010) Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol 126:1304-5.e3
McDonald, Douglas R; Goldman, Frederick; Gomez-Duarte, Oscar D et al. (2010) Impaired T-cell receptor activation in IL-1 receptor-associated kinase-4-deficient patients. J Allergy Clin Immunol 126:332-7, 337.e1-2
Detre, Cynthia; Keszei, Marton; Romero, Xavier et al. (2010) SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions. Semin Immunopathol 32:157-71
Sintes, Jordi; Romero, Xavier; de Salort, Jose et al. (2010) Mouse CD84 is a pan-leukocyte cell-surface molecule that modulates LPS-induced cytokine secretion by macrophages. J Leukoc Biol 88:687-97
Diamond, Betty; Cunningham-Rundles, Charlotte; Fischer, Alain et al. (2010) Josiah F. Wedgwood (1950-2009). J Allergy Clin Immunol 125:506

Showing the most recent 10 out of 107 publications